Chung Jane insider trades
Chung Jane has filed 22 Form 4s with the SEC that we hold, for Sutro Biopharma, INC. (STRO) (Chief Executive Officer, Director) and VIRX (Director). Across all of them we count 1 purchase worth $10.0K and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($10.0K) and 0 sales ($0). The largest single trade was a purchase of 12,500 shares of Sutro Biopharma, INC. worth $10.0K, dated 2025-10-15. The first filing on our record is dated 2021-08-11 and the latest 2026-03-06.
Sutro Biopharma, INC. (STRO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-10-15 | P, purchase reported on Form 4 | 12,500 | $10.0K | 2025-10-16 |
VIRX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1872398) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms